Table 1 Baseline characteristics of Risk & Prevention participants
| Â | % or mean (SD) |
|---|---|
Age (years) | Â |
   Mean | 63.9 (9.5) |
   ≤50 | 7.4 |
   51-59 | 22.9 |
   60-69 | 39.6 |
   70-79 | 27.0 |
   ≥80 | 3.0 |
Males | 61.5 |
Previous CVD | 29.6 |
Cardiovascular risk factors | Â |
   Hypertension | 84.6 |
   Hypercholesterolemia | 71.1 |
   Diabetes mellitus | 59.9 |
   Obesity | 48.6 |
   Family history of premature CVD | 31.1 |
   Cigarette smokers | 21.7 |
   Unhealthy diet | 63.9 |
   Physical inactivity | 56.1 |
   BMI (kg/m2) | 29.3 (4.9) |
   SBP (mmHg) | 140.2 (15.2) |
   DBP (mmHg) | 82.7 (8.2) |
   Heart rate (bpm) | 74.4 (8.4) |
   Total cholesterol (mg/dL) | 215.9 (42.6) |
   LDL cholesterol (mg/dL) | 132.1 (36.4) |
   HDL cholesterol (mg/dL) | 51.1 (13.3) |
   Triglycerides (mg/dL) | 168.7 (99.8) |
   Fasting blood glucose (mg/dL) | 132.8 (46.7) |
   * HbA1C (%) | 7.0 (1.5) |
Medical treatment | Â |
   ACE inhibitors | 45.1 |
   ARBs | 21.9 |
   Diuretics | 41.5 |
   Calcium - channel blockers | 28.2 |
   β-blockers | 20.6 |
   Oral hypoglycemic drugs | 44.1 |
   Insulin | 6.6 |
   Statins | 41.1 |
   Antiplatelet agents | 41.4 |